Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133375) titled 'Study on the Hepatic Effects of Dotinurad in Gout Patients with Fatty Liver Disease' on Sept. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Hospital
Condition:
Gout combined with fatty liver patients
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Treatment group(Dotinurad Tablets for urate lowering therapy):150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343247
Published by HT Digital Content Services with permission from Health Daily Digest....